Carregant...
Propranolol and breast cancer—a work in progress
The non-selective beta-blocker propranolol is a leading candidate for repurposing as a novel anti-cancer agent. Emerging evidence, including human data, suggests that there are multiple mechanisms of action particularly relevant to breast cancer. This editorial reviews a number of recent studies tha...
Guardat en:
| Publicat a: | Ecancermedicalscience |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cancer Intelligence
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027968/ https://ncbi.nlm.nih.gov/pubmed/30034523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.ed82 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|